Yunyi Le

408 total citations
16 papers, 311 citations indexed

About

Yunyi Le is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Yunyi Le has authored 16 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Molecular Biology. Recurrent topics in Yunyi Le's work include Pancreatic function and diabetes (10 papers), Diabetes Treatment and Management (6 papers) and Diabetes Management and Research (5 papers). Yunyi Le is often cited by papers focused on Pancreatic function and diabetes (10 papers), Diabetes Treatment and Management (6 papers) and Diabetes Management and Research (5 papers). Yunyi Le collaborates with scholars based in China and Canada. Yunyi Le's co-authors include Tianpei Hong, Rui Wei, Jin Yang, Kun Yang, Shan Lang, Junling Liu, Liangbiao Gu, Tianjiao Wei, Haining Wang and Xiaona Cui and has published in prestigious journals such as Metabolism, Peptides and Phytomedicine.

In The Last Decade

Yunyi Le

15 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yunyi Le China	8	178	150	133	59	44	16	311
Aika Miya Japan	10	252 1.4×	93 0.6×	105 0.8×	37 0.6×	76 1.7×	39	312
Shogo Funakoshi Japan	10	230 1.3×	223 1.5×	127 1.0×	107 1.8×	44 1.0×	17	395
V. Médeau France	6	217 1.2×	150 1.0×	73 0.5×	42 0.7×	28 0.6×	9	304
Rufei Shen China	10	135 0.8×	67 0.4×	111 0.8×	33 0.6×	62 1.4×	19	336
Husam Ghanim United States	9	223 1.3×	129 0.9×	140 1.1×	42 0.7×	121 2.8×	13	448
Dong-Jin Kim South Korea	6	94 0.5×	118 0.8×	95 0.7×	31 0.5×	36 0.8×	8	306
Toshikatsu Shigihara Japan	11	228 1.3×	229 1.5×	80 0.6×	160 2.7×	39 0.9×	20	427
Sudipta Bhattacharya United States	7	393 2.2×	132 0.9×	168 1.3×	24 0.4×	38 0.9×	12	473
K Haseroth Germany	7	141 0.8×	73 0.5×	113 0.8×	66 1.1×	64 1.5×	9	366
Per-Ola Carlsson Sweden	8	160 0.9×	215 1.4×	82 0.6×	129 2.2×	27 0.6×	9	372

Countries citing papers authored by Yunyi Le

Since Specialization

Citations

This map shows the geographic impact of Yunyi Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunyi Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunyi Le more than expected).

Fields of papers citing papers by Yunyi Le

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunyi Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunyi Le. The network helps show where Yunyi Le may publish in the future.

Co-authorship network of co-authors of Yunyi Le

This figure shows the co-authorship network connecting the top 25 collaborators of Yunyi Le. A scholar is included among the top collaborators of Yunyi Le based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunyi Le. Yunyi Le is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

J, Li, Dandan Wang, Fei Li, et al.. (2025). Mulberry twig (Sangzhi) alkaloids induce pancreatic α-to-β-cell phenotypic conversion in type 2 diabetic mice. Phytomedicine. 141. 156685–156685. 1 indexed citations

Le, Yunyi, Jingjing Zhang, Tianpei Hong, & Jin Yang. (2024). Coexistence of type 2 diabetes mellitus, arginine vasopressin deficiency, and Marfan syndrome: A case report. Journal of Diabetes Investigation. 15(7). 964–967. 1 indexed citations

Yang, Jin, Yafei Jiang, Tianjiao Wei, et al.. (2024). SGLT2 inhibitors ameliorate NAFLD in mice via downregulating PFKFB3, suppressing glycolysis and modulating macrophage polarization. Acta Pharmacologica Sinica. 45(12). 2579–2597. 26 indexed citations

Wu, Xiaolong, et al.. (2024). Vitamin D deficiency and the risk of diabetic retinopathy in patients with type 2 diabetes in Tibet: a cross-sectional analysis. BMC Endocrine Disorders. 24(1). 139–139. 3 indexed citations

Wang, Dandan, Tianjiao Wei, Xiaona Cui, et al.. (2024). Fam3a-mediated prohormone convertase switch in α-cells regulates pancreatic GLP-1 production in an Nr4a2-Foxa2-dependent manner. Metabolism. 162. 156042–156042. 1 indexed citations

Li, Lei, et al.. (2023). Potentially Inappropriate Medication Use Among Older Patients with Diabetes in a Chinese Community. Experimental and Clinical Endocrinology & Diabetes. 131(10). 548–553.

Le, Yunyi, Jin Yang, Fei Li, et al.. (2022). Dapagliflozin improves pancreatic islet function by attenuating microvascular endothelial dysfunction in type 2 diabetes. Diabetes/Metabolism Research and Reviews. 39(3). e3607–e3607. 5 indexed citations

Le, Yunyi, Kun Yang, Jin Yang, et al.. (2022). Association of Time in Range with Endothelial Injury in Patients with Type 2 Diabetes Treated with Exenatide. Diabetes Therapy. 13(10). 1755–1767. 2 indexed citations

Liu, Ye, Ran Lu, Junhong Wang, et al.. (2021). Diabetes, even newly defined by HbA1c testing, is associated with an increased risk of in-hospital death in adults with COVID-19. BMC Endocrine Disorders. 21(1). 56–56. 23 indexed citations

10.

Wei, Rui, Xiaona Cui, Jin Feng, et al.. (2020). Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice. Metabolism. 111. 154324–154324. 73 indexed citations

11.

Yang, Jin, Yunyi Le, Tianjiao Wei, et al.. (2020). Non-targeted metabolomic analysis predicts the therapeutic effects of exenatide on endothelial injury in patients with type 2 diabetes. Journal of Diabetes and its Complications. 35(2). 107797–107797. 5 indexed citations

12.

Lang, Shan, Jin Yang, Kun Yang, et al.. (2020). Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes. BMJ Open Diabetes Research & Care. 8(1). e001025–e001025. 32 indexed citations

13.

Liu, Junling, Kun Yang, Jin Yang, et al.. (2019). Liver-derived fibroblast growth factor 21 mediates effects of glucagon-like peptide-1 in attenuating hepatic glucose output. EBioMedicine. 41. 73–84. 64 indexed citations

14.

Le, Yunyi, Rui Wei, Kun Yang, et al.. (2019). Liraglutide ameliorates palmitate-induced oxidative injury in islet microvascular endothelial cells through GLP-1 receptor/PKA and GTPCH1/eNOS signaling pathways. Peptides. 124. 170212–170212. 26 indexed citations

15.

Wei, Rui, Liangbiao Gu, Jin Yang, et al.. (2019). Antagonistic Glucagon Receptor Antibody Promotes α-Cell Proliferation and Increases β-Cell Mass in Diabetic Mice. iScience. 16. 326–339. 32 indexed citations

16.

Liu, Junling, Kun Yang, Wenhua Xiao, et al.. (2018). GLP-1 receptor agonists stimulate ANGPTL8 production through the PI3K/Akt pathway in a GLP-1 receptor-dependent manner. Peptides. 106. 83–90. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact